Pharmaceutical Pricing and Healthcare Access

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-03-02-2004, Volume 28, Issue 3

Healthcare coverage and costs remain prime concerns for FDA as the number of uninsured Americans continues to grow.

Related Content:

Regulatory WatchPharmaceutical Technology-03-02-2004
Signing Off from Washington
Industry Challenges Medicare Price Negotiation Scheme
Drug Shortages Continue to Plague FDA and Manufacturers